List with SIG
Tap into the expertise of brokers who specialize in your property type.
Get In TouchGrifols Plasma Center | Phoenix, AZ
Grifols
4014-4020 North 19th Avenue, Phoenix, AZ, 85015, USA
Sands Investment Group is Pleased to Exclusively Offer For Sale the 8,615 SF Grifols Plasma Center NNN Asset Located at 4014-4020 North 19th Avenue in Phoenix, AZ. This Deal Includes a Corporate-Backed Lease With Grifols, One of the World’s Largest Plasma Collection Companies. Located in a Dense Area of Phoenix, the Property Offers Annual Rent Increases and Strong Real Estate Fundamentals, Making it a Highly Secured Investment.
Established Plasma Donation Location:
- This Site Has Been an Extremely Successful Plasma Center Since 1992; Reaching an Impressive Accomplishment of Continuous, Strong Enterprise Performance For Over Three Decades, Signifying Perfect Demographic Alignment
- Grifols Has Assumed the Lease Originally Dated April 23, 1996, With American Plasma Services LP., Demonstrating a Consistent Commitment to This Site as a Successful and Long-Standing Plasma Donation Center
Strong Guarantor:
- Fitch Ratings Has Revised the Outlook On Grifols, S.A.’s Long-Term Issuer Default Rating (IDR) to Stable and Affirmed the IDR at ‘B+’
- Grifols Reported an 8.7% Revenue Growth in 2023, Reaching $7.25 Billion; For the First Half of 2024, Revenue Grew By 7.5% Year-Over- Year to $3.85 Billion, Driven Primarily By a 13.3% Increase in the Biopharma Division, Due to Strong Plasma Supply and High Demand For Key Proteins
Increased Industry Demand:
- Global Demand For Plasma Has Risen Sharply Due to the Growing Prevalence of Immune Disorders, Neurological Conditions and Rare Diseases: The Plasma Market is Projected to Increase From $33.2 Billion in 2022 to $45.7 Billion By 2027, Reflecting This Significant Growth
Sticky Tenant:
- The Average Buildout Cost For a Plasma Donation Center Typically Ranges From $1 Million to $3 Million, Depending on the Size of the Facility, its Location and Specific Requirements For Medical Equipment; Costs Are Driven By the Need For Specialized Infrastructure, Such as Plasma Storage, Laboratory Spaces and Patient Donation Areas, All of Which Must Meet Stringent Health and Safety Standards
Dense Demographics:
- There Are Over 175,000 People Within a 3-Mile Radius and 466,215 Within a 5-Mile Radius; With an Annual Growth Projection of 1.6% Over the Next 5 Years
Strategic Location:
- The Property is Situated at the Intersection of West Indian School Rd (With a Traffic Volume of Over 36.000 Vehicles Per Day) and N 19th Avenue (With a Traffic Volume of Over 25,000 Vehicles Per Day); It is Positioned Between the Piestewa Freeway and the Arizona Veterans Highway. Which Encircle the Phoenix Metropolitan Statistical Area (MSA)
- The Property is Less Than 3-Miles From Grand Canyon University, Which Has Experienced Remarkable Growth in Recent Years, With Student Enrollment Surpassing 100,000 and Significant Upgrades to its Physical Campus
- Phoenix Sky Harbor International Airport and St. Joseph’s Hospital Are Also in Close Proximity; Neighboring Retail Includes Safeway, Sprouts, Food City, CVS and Costco
In Cooperation With Sands Investment Arizona, LLC – Lic. #LC690889000 BoR: Gary W. Berwick, CCIM – Lic. AZ #BR625869000
Grifols
4014-4020 North 19th Avenue, Phoenix, AZ, 85015, USA
GRIFOLS PLASMA CENTER
Grifols is a leading international healthcare company that has focused on enhancing the health and well being of people across the globe since 1909. They are the world’s largest producer of plasma-based products, plasma-derived medication, and transfusion medicines. Grifols develops, produces, and provides healthcare services and solutions in more than 100 countries, serving the need for knowledge and expertise in chronic, prevalent, and rare diseases. They specifically focus on treating conditions for a multitude of prominent therapeutic areas, such as: neurology, immunology, hepatology and intensive care, pulmonology, hematology, and infectious diseases. Innovation in both plasma and pharmaceutical sectors has allowed Grifols to remain at the forefront of modern medicinal success – last year Grifols drove over $7million in revenue, which helped them secure $1.6billion of additional financing. These impressive accomplishments resulted in elevated credit ratings, confirming the continued positive trajectory that the company has been on for over a century. Grifols continues to grow its network of donation centers, which is the world’s largest. This pioneer medical company has more than 24,000 employees in over 30 countries, and is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership.
Similar Listings
Southern Plains Medical Center 2-Unit Portfolio – OK
Oklahoma City, Oklahoma
Cap Rate: 8.25%
$12,023,030
Available
Price
SOLD
Cap Rate
8.00%
PREMISES
8,615 SF
RENEWAL OPTIONS
1 x 3 (RTM)
Lease Expiration
03/31/2027
Lease Type
NNN
RENTAL INCREASES
Annually in Accordance W/ Current CPI Index of All-Urban Wage Index
BROKERS
Get Property Updates in Your Inbox
Subscribe to the SIG newsletter to access properties before they come to market.
To receive access to this OM, please review and sign our confidentiality agreement:
Sands Investment Group (“Broker”) is presenting for sale the Subject Property (“Property”) referenced above, by the Property’s owner (the “Owner”). Our agreement with the Owner requires that we obtain a Non-Disclosure before disclosing the name and location of his/her location of his/her business. The undersigned (“Recipients”) hereby acknowledge and agree that certain confidential information that has been or may be disclosed is intended solely for Recipients’ limited use in considering whether to pursue negotiations to acquire the Property.
Neither the Owner of the Property nor Broker or any of their respective officers, employees or agents, make any representation or warranty, expressed or implied, as to the accuracy or completeness of this confidential information and no legal liability is assumed or shall be implied with respect thereto. Information provided has been or will be gathered from sources that are deemed reliable; however, neither Owner nor Broker warrants or represents that the information is true or correct. Recipients are advised to verify information independently. Owner and/or Broker reserve(s) the right to change the Property’s purchase price, or any Property or market information provided, or to withdraw the Property from the market at any time without notice.
Recipients agree that the information provided by Broker is confidential and as such, agrees to hold and treat such information in the strictest of confidence. In addition, Recipients agree not to disclose, directly or indirectly, or permit anyone else to disclose this information to any person, firm or entity without prior written authorization of Owner or Broker and not use, or permit to be used this information in any fashion or manner detrimental to the interests of Owner or Broker. Photocopying or other duplication of such confidential information is strictly prohibited. Recipients agree not to contact the Property’s tenant(s), leasing brokers, or property management staff in connection with Recipients’ review of the Property or confidential information. IN ADDITION, THE CONFIDENTIAL INFORMATION SHALL NOT BE DEEMED AS REPRESENTATIVE OF THE STATE OF AFFAIRS OF THE PROPERTY OR CONSTITUTE AN INDICATION THAT THERE HAS BEEN NO CHANGE IN THE BUSINESS OR AFFAIRS OF THE PROPERTY SINCE THE DATE OR PREPARATION OF THE OFFERING MEMORANDUM.
While Owner and/or Broker may discuss the purchase and sale of the Property with Recipients, either Owner or Broker, in our sole and absolute discretion, may terminate sale discussions at any time and for any reason. Recipients acknowledge that neither Owner nor Broker has any obligation to discuss or agree to the sale of the Property. The acquisition discussions may be lengthy and complex. Notwithstanding that the parties may reach one or more oral understandings or agreements on one or more issues, neither of the parties shall be bound by any oral agreement of any kind, and no rights, claims, obligations or liabilities of any kind, either expressed or implied, shall arise or exist in favor of or be binding upon either Owner or Broker except to the extent expressly set out in a written agreement signed by both Owner and Broker.
This letter will further confirm that Recipients understand that Broker is presenting the information on the above-referenced Property and that Recipients agree that all initial correspondence and agreements pertaining to the opportunities and subsequent purchase shall be submitted through Agent. Prospective Buyer shall not contact the Owner directly unless given written permission by Agent or act either directly, indirectly, through any third parties including affiliates, other clients or other brokers to circumvent the purpose of this Agreement.
The term of this Agreement is for one (1) year from the date below, which shall be automatically extended through any ongoing negotiations, escrow periods or closing of any purchase and sales transaction(s) for the opportunity entered into by Prospective Buyer or its affiliates during the term hereof.
By filling in your information and submitting this form, you are accepting the terms of this agreement.